Efficacy of Lorlatinib in Primary Crizotinib-Resistant Adult Neuroblastoma Harboring
ALK
Y1278S Mutation
JCO Precis Oncol
.
2019 Dec:3:1-5.
doi: 10.1200/PO.18.00396.
Authors
Antoine Vasseur
1
,
Luc Cabel
1
,
Romain Geiss
1
,
Gudrun Schleiermacher
1
,
Gaëlle Pierron
1
,
Maud Kamal
1
,
Nina Jehanno
1
,
Guillaume Bataillon
1
,
Jean-Marc Guinebretiere
1
,
Laurence Bozec
1
Affiliation
1
Institut Curie, Saint-Cloud, France.
PMID:
35100701
DOI:
10.1200/PO.18.00396
No abstract available